Physician profile
Markus Niederwanger
NPI 1508858887
$11,977.10
in general payments reported to CMS, 2019-2025
29 companies · $1,468 in 2025
The $1,468 reported for 2025 was more than what 91% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,572 · 2020: $628 · 2021: $1,174 · 2022: $959 · 2023: $2,808 · 2024: $3,368 · 2025: $1,468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,107 · Travel and Lodging: $1,713 · Consulting Fee: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,106.53 |
| Travel and Lodging | $1,712.98 |
| Consulting Fee | $825.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,307.04 | 2019-2025 | Wavewriter Alpha Prime 16, Na, General - Pain Management |
| Collegium Pharmaceutical, INC. | $623.62 | 2021-2025 | Belbuca, Xtampza |
| Scilex Pharmaceuticals INC. | $463.11 | 2019-2023 | Ztlido |
| Abbott Laboratories | $406.37 | 2019-2025 | Proclaim, Eterna |
| Nevro Corp. | $301.24 | 2019-2024 | Senza |
| Spr Therapeutics, INC | $270.51 | 2024-2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $213.39 | 2025 | Evoke |
| Biodelivery Sciences International, INC. | $173.27 | 2019-2021 | |
| Forte Bio-Pharma LLC | $172.44 | 2020-2024 | Prolate, Nalocet |
| Sentynl Therapeutics, INC. | $171.92 | 2019-2020 | |
| Abbvie INC. | $157.03 | 2022-2025 | |
| Globus Medical, INC. | $107.71 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $106.27 | 2024-2025 | |
| Pfizer INC. | $75.58 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $74.88 | 2022-2025 | Relistor |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $66.36 | 2021 | |
| Amgen INC. | $35.64 | 2021-2025 | Prolia, Evenity |
| Stryker Corporation | $32.67 | 2025 | Mild Device Kit |
| Avanos Medical | $28.35 | 2024 | Coolief* Cooled Radiofrequency |
| Pacira Therapeutics, INC. | $24.25 | 2019 | |
| Painteq LLC | $22.65 | 2024 | Painteq |
| Allergan, INC. | $22.02 | 2022 | |
| Ibsa Pharma INC. | $18.51 | 2021 | |
| Protega Pharmaceutials INC | $18.48 | 2023 | Roxybond |
| Medtronic, INC. | $18.19 | 2022 | |
| Shionogi INC | $18.13 | 2019 | |
| Arbor Pharmaceuticals, INC. | $16.96 | 2019 | |
| Redhill Biopharma INC. | $16.64 | 2020 | |
| Tonix Medicines, INC. | $13.87 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Markus Niederwanger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.